Abstract
416a – Vedolizumab Shows Superior Efficacy Versus Adalimumab: Results of Varsity—The First Head-To-Head Study of Biologic Therapy for Moderate-To-Severe Ulcerative Colitis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have